Position in SPRY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,718,201
+$68,783 QoQ
Shares Held
214,507
+4.4% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#43
of 206 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FAS Wealth Partners, Inc. holds $29,966,169 across 2 Biotechnology names. SPRY ranks #2 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
324,876 | $28,247,968 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
This page
|
214,507 | $1,718,201 |
All Filings in SPRY
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,718,201 | 214,507 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,649,418 | 205,407 | Shares | Sole | 2026-06-10 | |
| 2025-12-31 | $2,358,041 | 202,407 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,016,231 | 200,620 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,602,842 | 149,160 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,755,350 | 139,535 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $999,137 | 94,705 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,230,397 | 84,855 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $575,752 | 67,656 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $618,003 | 60,470 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $251,915 | 45,970 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $173,766 | 45,970 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $229,475 | 34,250 | Shares | Sole | 2023-08-08 | |
| No filing history on record for this holder in this stock. | ||||||